causal
Uncertainty in drug data benefits manufacturers
Because only about a third of cancer drugs have reliable survival data—many being approved on uncontrolled single-arm studies showing tumor shrinkage without a control group—there is large uncertainty about real benefit, and this uncertainty benefits manufacturers because tolerating uncertainty lets drugs reach market that otherwise could not.
causalpending
Speaker
Vinay PrasadEvidence Quote
“that uncertainty benefits the makers of the product. They want the uncertainty”
Created: 6/13/2026, 3:32:57 AM
Your notes
Loading notes...